Studies of Neuregulin/ERBB Signaling in Human Heart

Part of paid clinical trials in Portland, Maine.

Sponsor
Douglas B. Sawyer
Study ID
NCT02820233
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This study examines the role of the epidermal growth factor (EGF) receptor family and the EGF family of ligands in the regulation of non-myocytes isolated from the human heart.

Key Dates

Start date
Jun 30, 2015
Status verified
Jul 2024
Primary completion
Sep 30, 2028
Completion
Jun 30, 2029

Study Design

Enrollment
80 participants (estimated)

Primary Outcome Measure

The number of highly proliferative clones isolated [ Time Frame: up to 14 days from isolation ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Maine Medical CenterPortlandMaine04102
Joanne Burgess, RN
[email protected]
207-662-2414

Find similar trials in Portland, ME

By condition
Heart failure
By specialty
CardiologyHeart disease
By research site
Maine Medical Center· Portland, ME

Related Studies